Departments, Centers, & Programs:
55 Fruit Street
Boston, MA 02114-2696
- MD, University of Missouri-Kansas City School of Medicine
- Residency, Beth Israel Deaconess Medical Center
- Fellowship, Beth Israel Deaconess Medical Center
- Fellowship, University of Texas Health Science Center
American Board Certifications
- Cardiovascular Disease, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Wood was PI of an echocardiographic study, Echocardiographic Assessment of Changes in Left Ventricular Systolic and Diastolic Function with Prolonged Strenuous Exercise. It enrolled nearly 80 subjects and examined changes in systolic and diastolic function that occur after short and long distance strenuous exercise. Her team quantified serum biomarkers in athletes who ran in the 2004/2005 Boston Marathon, presented data nationally and published manuscripts in the European Heart Journal and Circulation in 2006.
She was also co-PI of the study, Echocardiographic Assessment of Changes in Left Ventricular Systolic and Diastolic Function in Elite Endurance Athletes, involving echocardiographic evaluation of Olympic speed skaters. It examined the effect of intense training and short duration, high-intensity exercise on systolic and diastolic left and right ventricular function. She helped develop the Harvard Athlete Initiative, a 3 year project involving electrocardiographic and echocardiographic screening of athletes.
She served as PI for the HAPPY Heart study, examining cardiovascular disease prevention in low income women with cardiovascular risk factors. Subjects in the study received an evaluation of risk factors, exercise ability and psychosocial factors. It includes echocardiography and carotid intimal-medial thickness measurement. This 2 year program lead to significant improvements in heart disease risk factors, stress and anxiety levels, Dr. Wood is the co-PI for the NIRVANA trial which examines the use of nevibool in symptom relief and exercise tolerance in microvascular ischemia. She is also co-PI of a prospective study examining clinical and genetic features in adults with a history of spontaneous coronary artery dissection.